Phase III randomized clinical trials global distribution and funding: Trends and disparities.

被引：0
|
作者：
Pinheiro, Karina
Ribeiro, Mauricio
Gadotti, Luiza Lara
Marson, Fabiane
Holanda Lopes, Carlos Diego
Saddi, Rodrigo
Machado Alessi, Joao Victor
Katz, Artur
机构：
[1] Hosp Sirio Libanes, Sao Paulo, Brazil
[2] Hosp Sirio Libanes, Sao Paulo, Brazil
[3] Hosp Sirio Libanes, Sao Paulo, Brazil
[4] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18563
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Funding of Phase III Clinical Trials Examining Radiation Compared With That of Other Modalities
    Lloyd, S.
    Buscariollo, D.
    Gross, C. P.
    Makarov, D. V.
    Yu, J. B.
    Aneja, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S44 - S45
  • [2] Control of false positives in randomized phase III clinical trials
    Shen, Changyu
    Liu, Ziyue
    Xu, Huiping
    Liu, Hai
    Yue, Cynthia
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (05) : 719 - 731
  • [3] Disparities in multinational phase III liver cancer clinical trials by regions of the world
    Maldonado, J. Alberto
    McGlynn, Katherine A.
    Greten, Tim F.
    Monge, Cecilia
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [4] Trends in the crossover of patients in phase III oncology clinical trials in the USA
    Yeh, Justin
    Gupta, Shruti
    Patel, Sunny J.
    Kota, Vamsi
    Guddati, Achuta K.
    [J]. ECANCERMEDICALSCIENCE, 2020, 14
  • [5] Trends in Crossover of Patients in Phase III Clinical Trials for Hematologic Malignancies
    Yeh, Justin
    Pappoppula, Lakshmi Priyanka
    Kota, Vamsi
    Jillella, Anand
    Guddati, Achuta Kumar
    [J]. BLOOD, 2019, 134
  • [6] Global Risk Reduction: A Novel Method To Estimate The Impact Of Multiple Intervention Trials To Reduce Stroke Disparities.
    Richards, Adam K.
    Bryg, Robert J.
    Cheng, Eric M.
    Towfighi, Amytis
    Jackson, Nicholas
    Brown, Arleen F.
    Barry, Frances
    Li Ning
    Vickrey, Barbara G.
    [J]. STROKE, 2016, 47
  • [7] Ethics and practice: Alternative designs for phase III randomized clinical trials
    Palmer, CR
    Rosenberger, WF
    [J]. CONTROLLED CLINICAL TRIALS, 1999, 20 (02): : 172 - 186
  • [8] Characterization of discontinuation and nonpublication of phase III randomized clinical trials of psoriasis
    Lam, Megan
    Monaghan, Caitlin
    Chan, An-Wen
    Drucker, Aaron M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (01) : 127 - 129
  • [9] Global Imbalances in Funding Sources for HIV Randomized Control Trials
    John, Daniel Owoicholofu
    Wang, Peng
    Togo, Yaya
    McGovern, Mark
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2023, 39 (02) : 53 - 56
  • [10] Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer
    Fernandez-Lopez, Cristina
    Exposito-Hernandez, Jose
    Pedro Arrebola-Moreno, Juan
    Angel Calleja-Hernandez, Miguel
    Exposito-Ruiz, Manuela
    Guerrero-Tejada, Rosa
    Linares, Isabel
    Cabeza-Barrera, Jose
    [J]. CANCER MEDICINE, 2016, 5 (09): : 2190 - 2197
12345